newsfilter
← Latest News
Business Wire·

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the first quarter of 2026 after the market closes